Hilma Biocare – Tirzepatide (10ml/vial)
Tirzepatide is a dual-action GIP/GLP-1 receptor agonist for weight reduction and metabolic improvement through subcutaneous injection.
- The description claims that Tirzepatide provides stronger appetite suppression and fat-loss efficiency compared to single-pathway compounds.
AI Readiness
Good foundation, but some important product data is still missing.
72%